Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04626479
Title Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | NLD | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of California at San Francisco ( Site 1008) San Francisco California 94158 United States Details
Yale-New Haven Hospital-Yale Cancer Center ( Site 1011) New Haven Connecticut 06510 United States Details
University of Chicago ( Site 1013) Chicago Illinois 60637 United States Details
University of Iowa ( Site 1012) Iowa City Iowa 52242 United States Details
Henry Ford Health System ( Site 1014) Detroit Michigan 48202 United States Details
Laura and Isaac Perlmutter Cancer Center ( Site 1016) New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center ( Site 1002) New York New York 10065 United States Details
Duke Cancer Institute ( Site 1015) Durham North Carolina 27710 United States Details
UPMC Cancer Center/Hillman Cancer Center ( Site 1017) Pittsburgh Pennsylvania 15232 United States Details
UTSW Medical Center ( Site 1003) Dallas Texas 75390 United States Details
Western Sydney Local Health District ( Site 1601) Blacktown New South Wales 2148 Australia Details
St George Hospital ( Site 1602) Kogarah New South Wales 2217 Australia Details
Royal Brisbane and Women s Hospital ( Site 1603) Herston Queensland 4029 Australia Details
Austin Health ( Site 1600) Heidelberg Victoria 3084 Australia Details
Princess Margaret Cancer Centre ( Site 1101) Toronto Ontario M5G 1Z5 Canada Details
Jewish General Hospital ( Site 1100) Montreal Quebec H3T 1E2 Canada Details
James Lind Centro de Investigación del Cáncer ( Site 2108) Temuco Araucania 4800827 Chile Details
CIDO SpA-Oncology ( Site 2106) Temuco Araucania 4810148 Chile Details
FALP-UIDO ( Site 2100) Santiago Region M. De Santiago 7500921 Chile Details
Oncovida ( Site 2107) Santiago Region M. De Santiago 7510032 Chile Details
Bradfordhill-Clinical Area ( Site 2101) Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 2103) Viña del Mar Valparaiso 2520598 Chile Details
Sociedad De Oncologia Y Hematologia Del Cesar-Oncology ( Site 1905) Valledupar Cesar 200001 Colombia Details
Oncomédica S.A.S ( Site 1904) Montería Cordoba 230002 Colombia Details
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 1900) Bogota Distrito Capital De Bogota 111321 Colombia Details
Fundación Valle del Lili ( Site 1901) Cali Valle Del Cauca 760032 Colombia Details
Institut De Cancerologie De Lorraine ( Site 1204) Vandoeuvre les Nancy Ain 54519 France Details
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 1203) Strasbourg Alsace 67200 France Details
Institut Claudius Regaud ( Site 1200) Toulouse Cedex 9 Haute-Garonne 31059 France Details
Gustave Roussy ( Site 1202) Villejuif Val-de-Marne 94800 France Details
Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 2301) Budapest Pest 1122 Hungary Details
Rambam MC ( Site 1500) Haifa 3525408 Israel Details
Hadassah Medical Center-Oncology ( Site 1504) Jerusalem 9112001 Israel Details
Rabin Medical Center ( Site 1502) Petah Tiqwa 4941492 Israel Details
Sheba Medical Center - Oncology Division ( Site 1501) Ramat Gan 52621 Israel Details
Sourasky Medical Center ( Site 1503) Tel Aviv 6423906 Israel Details
Asan Medical Center ( Site 1800) Songpagu Seoul 05505 Korea, Republic of Details
Severance Hospital ( Site 1802) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 1801) Seoul 06351 Korea, Republic of Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 2402) Amsterdam Noord-Holland 1066CX Netherlands Details
Erasmus Medisch Centrum ( Site 2401) Rotterdam Zuid-Holland 3015 GD Netherlands Details
Auckland City Hospital ( Site 1700) Auckland 1023 New Zealand Details
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2201) Bydgoszcz Kujawsko-pomorskie 85-796 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 2200 Warszawa Mazowieckie 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 2202) Gdańsk Pomorskie 80-952 Poland Details
Hospital Universitari Vall d Hebron ( Site 1300) Barcelona Cataluna 08035 Spain Details
Hospital Universitario Ramon y Cajal ( Site 1301) Madrid 28034 Spain Details
Southampton General Hospital ( Site 1403) Southampton England SO16 6YD United Kingdom Details
The Beatson West of Scotland Cancer Centre ( Site 1405) Glasgow Glasgow City G12 0YN United Kingdom Details
Royal Preston Hospital ( Site 1406) Preston Lancashire PR2 9HT United Kingdom Details
Leicester Royal Infirmary ( Site 1408) Leicester Leicestershire LE1 5WW United Kingdom Details
Barts Health NHS Trust ( Site 1401) London London, City Of EC1A 7BE United Kingdom Details
Western General Hospital ( Site 1402) Edinburgh Midlothian EH4 2XU United Kingdom Details
Velindre Cancer Centre Hospital ( Site 1407) Cardiff Wales CF14 2TL United Kingdom Details
The Christie NHS Foundation Trust ( Site 1400) Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field